Sharda Cropchem Limited, one of the leading players in the crop protection chemicals industry, has announced its unaudited consolidated financial results for the quarter and nine months ended December 31, 2025, reporting robust growth across revenues, volumes, and profitability.

For the quarter ended December 31, 2025 (Q3 FY26), the company recorded consolidated revenues of Rs. 1,289 crore, marking a 39 per cent year-on-year increase, driven by higher volumes and a favourable product mix. Europe emerged as the largest contributor in both value and volume terms during the quarter.

Gross margins expanded by 220 basis points to 34.9 per cent, supported by stabilising input costs, improving price dynamics, and a change in product mix. EBITDA rose 59 per cent year-on-year to Rs. 246 crore, with EBITDA margins improving by 250 basis points to 19.1 per cent.

For the nine months ended December 31, 2025 (9M FY26), consolidated revenues increased 29 per cent year-on-year to Rs. 3,203 crore, while EBITDA grew 64 per cent to Rs. 527 crore. The company achieved its highest-ever annual PAT of Rs. 362 crore within the first nine months of FY26.

Segment and Volume Performance

During Q3 FY26, the Agrochemical segment contributed 89 per cent of total revenues, while the Non-Agrochemical segment accounted for 11 per cent. Overall volumes increased 14.4 per cent year-on-year, with agrochemical volumes growing 14.5 per cent and non-agrochemical volumes rising 13.5 per cent.

For 9M FY26, the Agrochemical segment contributed 87 per cent of revenues and the Non-Agrochemical segment 13 per cent. Overall volumes grew 20.2 per cent year-on-year, driven by 20.1 per cent growth in agrochemicals and 24.0 per cent growth in non-agrochemicals.

Balance Sheet and Operational Highlights

Capital expenditure during 9M FY26 stood at Rs. 399 crore, reflecting continued investments in growth and registrations. As of December 31, 2025, the company held 3,004 product registrations, with 1,076 applications pending at various stages of approval.

Sharda Cropchem remains debt-free, with cash, bank balances, and liquid investments of Rs. 826 crore, providing significant financial flexibility.

Management Commentary

Commenting on the results, Ramprakash Bubna, Chairman and Managing Director, said the company delivered strong growth momentum during the quarter, led by Europe and supported by improving margins.

He noted that stabilising input costs and favourable pricing trends have contributed to margin expansion and added that the company expects gross profit margins to remain in a similar range going forward. The company anticipates continued growth momentum in the fourth quarter of FY26 and expects performance to remain strong in FY27.